Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Elon Musk gets the OK for brain implants, and everyone's making the same joke

Neuralink gets the green light to test its brain-computer interface with human subjects

Creating a sperm or egg from any cell? Reproduction revolution on the horizon

Researchers are inching closer to creating human eggs and sperm in the lab that carry a full complement of anyone's DNA. It could revolutionize fertility treatment and raises huge ethical questions.

WEKU

Elon Musk’s Brain Chip Company Gets FDA Greenlight For ‘First-In-Human Clinical Study’

Neuralink gets FDA approval for human trial, a major stride in Musk's brain-implant tech vision.

Zenger

From analysis to the latest developments in health,
read the most diverse news in one place.

Elon Musk battles regulators and animal-cruelty allegations to launch brain-implant trials

Elon Musk's Neuralink can start its first human clinical trial of brain implants, as it faces probes over animal experiments.

The New Daily

Key facts about Neuralink, Musk's cyborg gamble

WASHINGTON - Neuralink, Elon Musk's brain-implant company, has won US approval to test on humans. Here is what to know about the multi-billionaire's dream project to enable the human brain to communicate directly with computers.

Bangkok Post

Oh good: Elon Musk's Neuralink gets FDA approval to put microchips in human brains

This is fine!

PC Gamer

This is your brain on Elon Musk

The multi-tasking, helter-skelter billionaire wants to put chips in our brains with his Neuralink company, and the FDA just gave him the go-ahead.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Civil service unions enter new pay talks with UK government

Prospect and FDA suspend strike action after offer of ‘meaningful’ talks, with PCS also attending

The Guardian - UK

Musk's Neuralink says it won FDA approval for human trials

Elon Musk's Neuralink said it has been cleared by the FDA to begin human trials on its brain-implant technology.

Axios

Elon Musk says his Neuralink brain chips have been approved for trials on humans

Patients have been able to register their interest to enroll in tests since earlier in the year

Evening Standard

Elon Musk's 'mind control chip' is cleared for human testing despite monkey deaths

Human trials will start soon on a brain implant which aims to help treat people with autism, obesity and a range of other conditions, despite earlier rejections over animal deaths

Daily Mirror

B4 million in fake herbal products seized

Police have confiscated fake herbal products worth about 4 million baht during raids on four locations in Bangkok and Pathum Thani following an investigation into sales of the products by Chinese nationals to Chinese tourists.

Bangkok Post

Elon Musk’s Neuralink brain chip company says it now has FDA approval for human testing

Brain chip firm has reportedly killed about 1,500 animals, including over 280 sheep, pigs and, monkeys

The Independent UK

Elon Musk's futuristic brain chip startup Neuralink gets FDA approval for human testing that 'represents an important first step'

Musk has pitched his startup and its technology, which requires drilling into patients' skulls, as potentially helping people with paralysis.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars

While rare diseases impact a small population, the cost to society is staggering. It may be in the range of $7.2-$8.6 trillion per year.

Salon

A psychedelic clue to the cause of SIDS

A new study using radioactive psychedelics suggests that infants who die of SIDS have abnormal serotonin receptors

The Independent UK

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid

Wales Online

Warning flesh-eating zombie drug could be widespread in UK after first death

It has contributed to an epidemic of drug deaths in the US

Get all your
news in one place.

100's of premium titles.
One news app.

Businessweek

There’s Still Scary Stuff in Sunscreen

Endocrine disrupters and other potentially dangerous ingredients persist despite FDA concerns.

Tribune News Service

Analysts expect Medtronic to deliver frank financial answers this week

Medtronic is facing sluggish sales growth, is in the midst of deep cost-cutting and started ongoing global layoffs in April. It's also spinning off businesses with weaker profit margins.

Tribune News Service

If Sen. John Cornyn is part of the ‘deep state,’ as Trump says, what exactly is the deep state?

WASHINGTON – Sen. John Cornyn earned a spot on Donald Trump’s naughty list by saying the GOP should pick someone else for president in 2024.

LiveScience

Extremely rare case of mad cow disease detected in the US

It is only the seventh case of the deadly disease reported in the U.S. since it first emerged in the country in 2003.

StockNews.com

4 Hyper-Growth Stocks That Could Soar

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….

Daily Mirror

First Brit to die of flesh-eating 'zombie drug' named as dad-of-two

Karl Warburton, 43, died last May from xylazine, which is used by vets as a tranquilliser for large animals such as horses and cows - the drug has never been approved for human use as it can cause flesh-rotting sores on takers’ skin

The Independent UK

‘Zombie drug’ could be widespread in UK, experts warn

Xylazine is a powerful sedative which has swept across the United States.

1 … 128 129 130 131

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.